The Differential Translation Capabilities of the Human DHFR2 Gene Indicates a Developmental and Tissue-Specific Endogenous Protein of Low Abundance.

Michelle M Murphy, Sandra C P De Castro, Aoife MacCooey, Linda Hughes, Kit-Yi Leung, Paola Drago, Niamh Bookey, Wendy E Heywood, Kevin Mills, Ivan Doykov, Nicholas D E Greene, Paul A Cahill, Denise Burtenshaw, Mari Ozaki, Anne Parle-McDermott, Paula Meleady, Michael Henry, Susan Campbell, Pere Cavallé-Busquets

Journal: Molecular & cellular proteomics : MCP 2024;23(3):100718

PMID: 38224738

Abstract

A functional role has been ascribed to the human dihydrofolate reductase 2 (DHFR2) gene based on the enzymatic activity of recombinant versions of the predicted translated protein. However, the in vivo function is still unclear. The high amino acid sequence identity (92%) between DHFR2 and its parental homolog, DHFR, makes analysis of the endogenous protein challenging. This paper describes a targeted mass spectrometry proteomics approach in several human cell lines and tissue types to identify DHFR2-specific peptides as evidence of its translation. We show definitive evidence that the DHFR2 activity in the mitochondria is in fact mediated by DHFR, and not DHFR2. Analysis of Ribo-seq data and an experimental assessment of ribosome association using a sucrose cushion showed that the two main Ensembl annotated mRNA isoforms of DHFR2, 201 and 202, are differentially associated with the ribosome. This indicates a functional role at both the RNA and protein level. However, we were unable to detect DHFR2 protein at a detectable level in most cell types examined despite various RNA isoforms of DHFR2 being relatively abundant. We did detect a DHFR2-specific peptide in embryonic heart, indicating that the protein may have a specific role during embryogenesis. We propose that the main functionality of the DHFR2 gene in adult cells is likely to arise at the RNA level.

Crown Copyright © 2024. Published by Elsevier Inc. All rights reserved.

Address: School of Biotechnology, Dublin City University, Dublin, Ireland; DCU Life Sciences Institute, Dublin City University, Dublin, Ireland. Electronic address: [email protected].; School of Biotechnology, Dublin City University, Dublin, Ireland; DCU Life Sciences Institute, Dublin City University, Dublin, Ireland.; Developmental Biology and Cancer Department, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.; School of Biotechnology, Dublin City University, Dublin, Ireland.; DCU Life Sciences Institute, Dublin City University, Dublin, Ireland.; Translational Mass Spectrometry Research Group, UCL Great Ormond Street Institute of Child Health, University College London, London, UK.; Area of Preventive Medicine and Public Health, Department of Basic Medical Sciences, Faculty of Medicine and Health Sciences, Universitat Rovira i Virgili, IISPV and CIBERobn (Instituto de Salud Carlos III), Reus, Spain.; Area of Obstetrics, Hospital Universitari Sant Joan de Reus, IISPV and CIBERobn (Instituto de Salud Carlos III), Reus, Spain.; Sheffield Hallam University, Department of Biosciences and Chemistry, Sheffield, UK.; School of Biotechnology, Dublin City University, Dublin, Ireland; DCU Life Sciences Institute, Dublin City University, Dublin, Ireland. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.